Dossier · Defunct or wound down · 11 independent sources
BioFishency
Last updated: Oct 4, 2026
BioFishency was an Israeli aquaculture-water-treatment startup that developed compact biological and electro-chemical systems for land-based and recirculating aquaculture. Public ecosystem data now marks the company non-active and reports that it ceased operating in January 2026, so this record is primarily a historical technology and strategic-relevance assessment.
Visit WebsiteCompany Overview
BioFishency developed water-treatment equipment for fish and shrimp farms, with a focus on land-based aquaculture and recirculating aquaculture systems (RAS). Its product descriptions centered on modular, plug-and-play treatment rather than on building an entire farm from scratch. The reported product family included the SPB biological filter and the ELX electro-chemical water-treatment platform. Public descriptions associate the systems with biological filtration, solids handling, ammonia and nitrite management, carbon-dioxide removal, oxygenation, disinfection, and tighter control of water exchange. The company also promoted electro-chemical treatment for removing off-flavor compounds such as geosmin and MIB, which can reduce the marketability of otherwise healthy farmed fish. These are meaningful operational problems: water chemistry directly affects fish survival, growth, stocking density, labor, discharge, and harvest quality.
The commercial customer is an aquaculture operator or integrator that needs more predictable production from constrained land and water resources. RAS can reduce water consumption and permit production close to markets, but it is equipment-intensive, energy-sensitive, and operationally unforgiving. BioFishency’s historical positioning was to lower the complexity or cost barrier for farms that could not justify a large bespoke RAS installation, while also helping existing ponds or tanks improve productivity. Public sources describe deployed or demonstrated systems in several geographies and species contexts, including fish, shrimp, and cold-water applications, but the available evidence does not establish a durable installed base, recurring service revenue, or current customer concentration. The strongest historical traction signals are a reported 2018 sales figure in Globes, a 2019 financing round, product demonstrations with research institutions, and later Israeli pilot-facility activity; each should be treated as a point-in-time signal rather than proof of present commercial scale.
Competition comes from specialist RAS designers, aquaculture filtration and oxygenation vendors, disinfection providers, and larger water-treatment companies that can bundle equipment, engineering, and service. BioFishency’s proposed differentiation was the integration of biological and electro-chemical treatment in a compact system, with off-flavor remediation as an additional product-quality argument. That bundle could reduce the number of separate subsystems a farm must procure, but it also creates validation and support burdens: operators need reliable performance across species, salinity, temperature, feed loads, and farm designs. The public record is not sufficient to compare lifecycle cost, energy consumption, uptime, maintenance intervals, intellectual-property defensibility, or field results against alternatives. Those gaps matter more than a broad claim of technical novelty because aquaculture infrastructure purchases are capital-sensitive and failures can cause immediate biological and financial losses.
For Claw & Talon, BioFishency is best understood as a historical resilience and water-efficiency case, not as a defense technology company. Reliable aquaculture can support food production in water-constrained or import-dependent regions, and compact treatment equipment may be useful in remote or controlled environments. That is a strategic adjacency, not substantive defense applicability: there is no reliable public evidence here of military customers, security missions, contested-logistics deployments, or defense procurement. The company’s January 2026 non-active status is the dominant current diligence fact. Any assessment of technology transfer, remaining intellectual property, installed equipment, liabilities, successor activity, or acquisition opportunities would require direct registry, creditor, asset, and management verification that is outside the public evidence captured in this record. Historical relevance remains useful for mapping Israeli water and food-resilience capabilities, but the company should not be treated as an active startup or current strategically relevant priority.
Strategic Fit Assessment
The historical technology addressed a real aquaculture bottleneck and attracted reported financing from The Trendlines Group and Aqua-Spark, but current public ecosystem data marks BioFishency non-active and reports that it ceased operating in January 2026. It is therefore not an active priority signal. Any residual strategic interest would require diligence on surviving intellectual property, installed systems, customer obligations, assets, and a legally valid successor or acquisition path.
Strategic Value to U.S.-Israel Alliance
Historical value as an Israeli example of water-efficient food-production infrastructure and aquaculture process engineering. The company has limited direct defense relevance, and its reported wind-down means current strategic value depends on whether technology, personnel, equipment, or intellectual property remain recoverable.
Key Technologies
- Recirculating aquaculture system water treatment
- Electro-chemical water treatment and disinfection
- Biological filtration for ammonia and nitrite control
- Mechanical solids filtration and water-quality conditioning
- Carbon-dioxide removal and oxygenation
- Geosmin and MIB off-flavor remediation
- Modular aquaculture process-control systems
Use Cases & Applications
- Land-based fish farming
- Recirculating fish-farm water treatment
- Warm-water shrimp production
- Cold-water aquaculture applications
- Ammonia and nitrite management in ponds and tanks
- Off-flavor reduction before fish harvest
- Water-saving production in resource-constrained locations
- Research and pilot aquaculture facilities
Sources and verification
This profile is based on public-source research, Claw & Talon curation, and editorial judgment. Inclusion does not imply endorsement, partnership, investment, or a recommendation to transact. Readers should still confirm current status, customers, funding, and product claims before relying on this profile. The editorial policy explains how profiles are researched, where automated drafting is used, and how corrections work; the research methodology documents how evidence is graded, what counts as an independent source, and why some profiles are excluded from search indexing.
This record lists 12 public references used for company identity, status, positioning, or material-claim review.
Public sources
The links below are visible public references used for source discipline around company identity, status, funding, customer, acquisition, public-company, or other material claims where available.
- BioFishency — Agriculture & Food Technologies | Finder Supports: company ceased operations and became non-active in January 2026; founded March 2013 by Cobi Levanon and Igal Magen; two reported financing rounds totaling $3.5 million, including 2013 seed and March 2019 round; Israeli company registration number 514894492; historical products, team, customers and locations
- BioFishency Raises $2.4 Million for its Water Treatment Systems for Aquaculture Supports: March 2019 completed $2.4 million investment round; 2018 sales exceeded $1.3 million and more than doubled 2017 revenue; historical markets and water reduction/yield claims
- Fish Farming Startup BioFishency Raises $2.4 Million Supports: March 2019 $2.4 million round led by Aqua-Spark and The Trendlines Group; 2018 sales over $1.3 million as company-reported; company founded in 2013 and land-based aquaculture focus
- The Trendlines Group Annual Report 2019 Supports: Trendlines initial investment in BioFishency in 2013; Trendlines reported 31.21 percent fully diluted ownership at 2019 year-end
- BioFishency Hails First-in-the-World Success in Electro-Chemical Removal of Off-Flavors Supports: March 2023 collaboration testing with Technion and company-reported ELX results; company product description, Israel founding, manufacturing locations, patented-technology assertion
- BioFishency Ltd. — Israel Innovation Authority award profile Supports: Israeli company registration number, 2013 founding, Atlit address, product description and leadership; support/winner entries dated 2022 and 2023; these are support records, not equity funding
- BIOFISHENCY LTD company information Supports: company status reported dissolved by court; incorporation date and Israeli private company status; January 2026 court liquidation notice and insolvency court docket
- A Novel Approach for Recirculating Aquaculture System Based on Physicochemical Water Treatment Process Supports: BioFishency ELX technical presentation and stated aquaculture problems
- About Us — The Trendlines Group Supports: Trendlines investment focus and public company identifiers
- The Fish Site: Funding windfalls for water treatment firms Supports: Aqua-Spark states it was a primary investor in BioFishency’s $2.4 million round
- BioFishency appoints new chairman of the board Supports: BioFishency appointed Ohad Maiman chairman in April 2023; report describes his AquaFounders Capital and Kingfish Company background
- Official website
- Profile update timestamp Last updated in the Claw & Talon database on Oct 4, 2026.
Related sector
See the Industrial, Energy & Climate sector page for market context, related subcategories, and other Israeli companies in this part of the database.